相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune targets and neoantigens for cancer immunotherapy and precision medicine
Rong-Fu Wang et al.
CELL RESEARCH (2017)
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer
Pierre P. Massion et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
Michael S. Khodadoust et al.
NATURE (2017)
Cancer Neoantigens and Applications for Immunotherapy
Alexis Desrichard et al.
CLINICAL CANCER RESEARCH (2016)
Proteomics of endometrial cancer diagnosis, treatment, and prognosis
Parul Mittal et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
The Emerging Role of B Cells in Tumor Immunity
Peiling Tsou et al.
CANCER RESEARCH (2016)
Prognostic and predictive value of tumor in early breast cancer
Carmen Criscitiello et al.
CANCER TREATMENT REVIEWS (2016)
Stable long-term cultures of self-renewing B cells and their applications
Mark J. Kwakkenbos et al.
IMMUNOLOGICAL REVIEWS (2016)
Autoantibodies against tumor-associated antigens in the early detection of lung cancer
Liping Dai et al.
LUNG CANCER (2016)
Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples
Tina Heyder et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis
Anna Sandstrom Gerdtsson et al.
MOLECULAR ONCOLOGY (2016)
Immune profiling players shift gear to guide cancer drug development
Michael Eisenstein
NATURE BIOTECHNOLOGY (2016)
Rekindling cancer vaccines
Malorye Allison Branca
NATURE BIOTECHNOLOGY (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer
Darshil T. Jhaveri et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations
Kevin K. Dobbin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V. Masucci et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Focus on Extracellular Vesicles: Introducing the Next Small Big Thing
Hina Kalra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Natural and Induced Antibody Polyreactivity
Annaelle Jarossay et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Discovering cancer biomarkers from clinical samples by protein microarrays
Bin Hu et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Autoantibody Signature for the Serologic Detection of Ovarian Cancer
Karen S. Anderson et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic?
Lahiru Gangoda et al.
PROTEOMICS (2015)
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J. Turley et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Immune biomarkers: the promises and pitfalls of personalized medicine
Joanna C. D. Willis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors
Juan Fu et al.
CANCER RESEARCH (2014)
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia et al.
CLINICAL CANCER RESEARCH (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Audit of the autoantibody test, EarlyCDT (R)-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice
James R. Jett et al.
LUNG CANCER (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Use of Autoantibodies to Detect the Onset of Breast Cancer
Jerome Lacombe et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis
Qing Zhu et al.
AUTOIMMUNITY REVIEWS (2013)
Current state of diagnostic technologies in the autoimmunology laboratory
Renato Tozzoli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
The developing schistosome worms elicit distinct immune responses in different tissue regions
Hamish E. G. McWilliam et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Novel immunomic technologies for schistosome vaccine development
H. E. G. McWilliam et al.
PARASITE IMMUNOLOGY (2012)
Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
Karina Martin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Autoantibody signatures: progress and perspectives for early cancer detection
C. Desmetz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Immunoscreening of the extracellular proteome of colorectal cancer cells
Susanne Klein-Scory et al.
BMC CANCER (2010)
Up-regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast
Pavel Gromov et al.
MOLECULAR ONCOLOGY (2010)
Control systems and decision making for antibody production
Christopher C. Goodnow et al.
NATURE IMMUNOLOGY (2010)
The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant
Michael de Veer et al.
VACCINE (2010)
Serum autoantibodies as biomarkers for early cancer detection
Hwee Tong Tan et al.
FEBS JOURNAL (2009)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients
Audrey Gagnon et al.
CLINICAL CANCER RESEARCH (2008)
Autoantibodies to tumor-associated antigens: reporters from the immune system
Eng M. Tan et al.
IMMUNOLOGICAL REVIEWS (2008)
Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray
Lan Li et al.
JOURNAL OF PROTEOME RESEARCH (2008)
The cancer secretome: a reservoir of biomarkers
Hua Xue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Immunoproteomics: From biomarker discovery to diagnostic applications
Harold Tjalsma et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells
Emiliano Pavoni et al.
BMC BIOTECHNOLOGY (2007)
Cancer immunomics using autoantibody signatures for biomarker discovery
Michel Caron et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Allergen-induced airway remodelling
C. M. Lloyd et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: Potential theranostic approach to cancer
Ramila Philip et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Protein microarray platforms for clinical proteomics
Harvey B. Pollard et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing
Wei-Hua Li et al.
PROTEOMICS (2006)
The 'reverse capture' autoantibody microarray: a native antigen-based platform for autoantibody profiling
Joshua R. Ehrlich et al.
NATURE PROTOCOLS (2006)
Tumour immunology - Tumour-induced immune modulation of sentinel lymph nodes
Alistair J. Cochran et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Naturally occurring B-cell responses to breast cancer
JA Coronella-Wood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3
MJ Nam et al.
PROTEOMICS (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)